The eight factors that will determine the impact of GLP-1s

Sizing the full, eventual impact of GLP-1s is difficult—here are the eight factors that will determine the size of their impact.

Yulan Egan
Yulan Egan
7 min read

In last week’s blog post, we delved into the what and why behind the current surge in interest and demand for GLP-1s. And it’s clear that these medications have significant potential to not only meaningfully improve patient outcomes, but also to reshape the business models underlying chronic care today. But sizing the full, eventual impact of these drugs remains difficult, given a large number of unknowns/lingering unanswered questions, and the fast pace of change when it comes to continued clinical innovation, as well as the shifting reimbursement and coverage landscape.

So in today’s blog, we’ll share the short-list of factors that we think will ultimately shape the magnitude of the impact of GLP-1s. For each factor, we’ll share: 1) Why it matters, 2) the current state, and 3) the future outlook.

Let’s talk.

Questions? Want to learn more about what Union can do for you? We’d love to hear from you.